Friday, April 28, 2017

BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA

* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)